6-deoxy-6-fluoronaltrexone

Known as: 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-fluoromorphinan, 6-desoxy-6-fluoronaltrexone, cyclofoxy 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-1999
01219871999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Opiate receptor avidity, roughly equivalent to the ratio of unoccupied receptor density to the receptor dissociation constant (B… (More)
Is this relevant?
1997
1997
Positron emission tomography was performed on 12 Alzheimer's patients and 12 age-matched normal controls following the… (More)
Is this relevant?
1991
1991
Brain distribution of the opiate receptor antagonist, cyclofoxy (CF), was evaluated at equilibrium in rats. A combination of i.v… (More)
Is this relevant?
1991
1991
beta-Funaltrexamine (beta-FNA) is an alkylating derivative of naltrexone. In addition to acting as an irreversible inhibitor of… (More)
Is this relevant?
1990
1990
The present study demonstrates that pretreatment of rat brain membranes with (+)-cis-3-methylfentanyl [(+)-cis-MF], followed by… (More)
Is this relevant?
1990
1990
The opiate antagonist (-)-cyclofoxy [(-)-CF] and the receptor inert enantiomer (+)-CF were radiolabeled with 18F or 3H and… (More)
Is this relevant?
1990
1990
The "rapid-phase" brain distribution of 3H-labeled enantiomers of the opiate receptor antagonist cyclofoxy (CF), receptor active… (More)
Is this relevant?
1988
1988
Norbinaltorphimine (nor-BNI) is a bifunctional reagent developed as a selective antagonist of the kappa opioid receptor. In this… (More)
Is this relevant?
1988
1988
17-Cyclopropylmethyl-3,14-dihydroxy-4,5-alpha-epoxy-6-beta-fluoromorp hinan (cycloFOXY) is a fluorinated derivative of naltrexone… (More)
Is this relevant?
1987
1987
Cyclofoxy, a fluorinated analog of naltrexone, has been designed specifically to permit in vivo labeling of opiate receptors in… (More)
Is this relevant?